Pages

Wednesday, April 26, 2017

Adamis Pharmaceuticals Announces Closing of Public Offering of ...

Nasdaq-2 hours ago
The Company's U.S. Compounding, Inc. subsidiary, which is registered as a drug compounding outsourcing facility under Section 503B of the U.S. Food, Drug ..